You are here: Industry Insights > Roche

News List

FDA accepts application for Roche’s Faricimab expresspharma
July 30, 2021
If approved, Faricimab would be the first and only medicine designed to target two distinct pathways that drive retinal diseases that can cause vision loss.
Roche records 8% increase in group sales for H1 2021 pharmaceutical-technology
July 26, 2021
Roche has reported an 8% increase in group sales to $33.46bn (CHF30.71bn) at constant exchange rates (CER) in the first half (H1) of 2021, as against $31.81bn (CHF29.28bn) in H1 last year.
Financial Report: Roche 1H Results contractpharma
July 23, 2021
Diagnostics Division sales grew 49% due to high demand for COVID-19 tests and strong momentum in routine testing.
FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic syndromes expresspharma
July 22, 2021
Every year, approximately 10,000 people are diagnosed with myelodysplastic syndromes (MDS) in the US, and there remains a high unmet need for new treatment options.
Japan First to Approve Roche’s Ronapreve to Treat COVID-19 contractpharma
July 22, 2021
Roche received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Ronapreve (casirivimab and imdevimab), for the treatment of mild to moderate COVID-19 via intravenous infusion.
New data for Roche’s Hemlibra reinforce safety profile in people with haemophilia A expresspharma
July 21, 2021
Final analysis from the phase-IIIb STASEY study, including data from 193 people with haemophilia A, further supports the benefit/risk profile of Hemlibra, with no new safety signals identified.
Treos Bio Enters into Clinical Collaboration to Evaluate its Polypeptide Cancer Immunotherapy PolyPEPI1018 in Combination with Roche’s PD-L1-Inhibitor firstwordpharma
July 08, 2021
Treos Bio Limited (“Treos”) today announced a clinical collaboration with Roche in which Treos will evaluate the combination of PolyPEPI1018, its lead product candidate, and atezolizumab, Roche’s PD-L1-inhibitor.
MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development b3cnewswire
July 07, 2021
MIMETAS announced today that they have entered into a collaboration to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV).
US approves Roche drug for emergency use against severe COVID-19 expresspharma
June 28, 2021
The US Food and Drug Administration (FDA) said yesterday that it had issued an emergency use authorisation (EUA) for Actemra to treat adults and pediatric patients hospitalised with COVID-19.
Roche SARS-CoV-2 Molecular Test Gets FDA Emergency Use Authorization for PCR Testing of both Symptomatic and Asymptomatic Individuals americanpharmaceuticalreview
June 23, 2021
The cobas SARS-CoV-2 test is the first RT-PCR test that screens within 20 minutes both asymptomatic and symptomatic persons, enabling quick, informed decisions at the point of care.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page